Early Engraftment and Immune Kinetics Following Allogeneic Transplant Using a Novel Reduced-Toxicity Transplant Strategy in Children/Adolescents with High-Risk Transfusion-Dependent Thalassemia: Early Results of the ThalFAbS Trial
Open Access
- 24 December 2024
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 31 (3) , 180.e1-180.e12
Abstract
No abstract availableKeywords
Funding Information
- Thalassemia Foundation of Canada
- The Garron Family Cancer Centre
This publication has 28 references indexed in Scilit:
- Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignanciesAnnals of Hematology, 2024
- Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directionsBlood Reviews, 2021
- Hematopoietic Stem Cell Transplantation for Severe Thalassemia Patients from Haploidentical Donors Using a Novel Conditioning RegimenTransplantation and Cellular Therapy, 2020
- Nonmyeloablative Matched Sibling Donor Hematopoietic Cell Transplantation in Children and Adolescents with Sickle Cell DiseaseTransplantation and Cellular Therapy, 2019
- Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell DiseaseTransplantation and Cellular Therapy, 2016
- Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk StratificationTransplantation and Cellular Therapy, 2014
- Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell PhenotypeJAMA, 2014
- Cytokine and Chemokine Patterns Across 100 Days after Hematopoietic Stem Cell Transplantation in ChildrenTransplantation and Cellular Therapy, 2014
- A New Stratification Strategy That Identifies a Subset of Class III Patients with an Adverse Prognosis among Children with β Thalassemia Major Undergoing a Matched Related Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2007
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005